Madrigal is a biopharmaceutical company dedicated to developing innovative therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a critical liver condition that can lead to severe health complications. With a focus on creating effective treatments like Rezdiffra, Madrigal aims to transform the standard of care for patients suffering from this serious disease.
No jobs found. Subscribe below to get notified when we find something for you.
Searching